The Future Of Multiple Myeloma Research And Treatment – Dr. Shaina Rozell

Описание: In this segment, Dr. Shaina Rozell explores where we stand today in the fight against multiple myeloma and what the future holds. With advances in multiple myeloma treatment, including quadruplet therapy and novel immunotherapies, researchers are pushing survival rates higher and getting closer to the possibility of a multiple myeloma cure.

A major focus of current research is minimal residual disease (MRD), which is now being used as a surrogate marker for progression-free survival and overall survival. By tracking MRD, physicians can better understand sustained response and long-term outcomes in myeloma treatment.

Dr. Rozell also highlights the evolving role of stem cell transplant and how it may change in the era of advanced therapies. Alongside this, she discusses innovations in clinical trial design, including more patient centric clinical trial design and modern clinical trial study design approaches that aim to improve real-world effectiveness.

What you’ll get to know in this segment:
▶ How quadruplet therapy and MRD tracking are reshaping multiple myeloma treatment
▶ The role of stem cell transplants in the future of myeloma care
▶ Why clinical trial design and trial design in clinical research must evolve
▶ How clinical trial participation can advance the path toward a multiple myeloma cure
▶ The importance of minority representation in trials for more equitable outcomes

The future of multiple myeloma research looks promising, with innovative therapies, smarter trial designs, and a stronger focus on patient-centered care.

#multiplemyeloma #clinicaltrials #mrd #quadruplettherapy #cancerresearch